|
GGTLC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.588600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.528800E-01 |
| Normal-vs-Stage2 |
3.272600E-01 |
| Normal-vs-Stage3 |
4.643000E-01 |
| Normal-vs-Stage4 |
1.668290E-02 |
| Stage1-vs-Stage2 |
1.170570E-01 |
| Stage1-vs-Stage3 |
7.701200E-01 |
| Stage1-vs-Stage4 |
2.495700E-02 |
| Stage2-vs-Stage3 |
1.253630E-01 |
| Stage2-vs-Stage4 |
8.560400E-03 |
| Stage3-vs-Stage4 |
8.058000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.158000E-01 |
| Normal-vs-AfricanAmerican |
3.573400E-01 |
| Normal-vs-Asian |
8.075600E-01 |
| Caucasian-vs-AfricanAmerican |
7.876000E-01 |
| Caucasian-vs-Asian |
2.919400E-01 |
| AfricanAmerican-vs-Asian |
3.532600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.684200E-01 |
| Normal-vs-Female |
4.657400E-01 |
| Male-vs-Female |
9.744000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.964400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.893800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.331800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.277600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.633200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.815200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.752800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.276600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.893800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.796000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.967400E-01 |
| Classical-VS-Follicular |
2.068400E-02 |
| Classical-VS-Other |
3.273800E-01 |
| Classical-VS-Normal |
1.677040E-01 |
| Tall-VS-Follicular |
2.596100E-02 |
| Tall-VS-Other |
3.650000E-01 |
| Tall-VS-Normal |
1.585390E-01 |
| Follicular-VS-Other |
2.786100E-02 |
| Follicular-VS-Normal |
2.614800E-01 |
| Other-VS-Normal |
8.322100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.743800E-01 |
| Normal-vs-N1 |
9.369000E-01 |
| N0-vs-N1 |
7.005200E-01 |
|
|
